MRK Archives - GroYourWealth.com

WSJ News Exclusive | Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion

Admin6 August 2022

Pfizer Inc. PFE -1.18% is in advanced talks to buy Global Blood Therapeutics Inc., GBT 33.03% the maker of a recently approved drug for sickle-cell disease, for about $5 billion,...

Business

U.S. Would Gain Power to Negotiate Drug Prices Under Manchin-Schumer Bill

Admin31 July 2022

A deal between Senate Democrats has revived legislation to significantly expand government regulation of prescription-drug prices and limit the out-of-pocket costs of Medicare seniors who use expensive medicines.If the bill...

Business

Drugmakers Hope New Heart Drugs Boost Sales, Revive Market

Admin27 July 2022

The once lucrative heart-drug market is now poised to make a comeback, but at the cost of heavy investments in research and deal making.After watching lower-priced generics seize sales of...

Business

WSJ News Exclusive | Merck Deal for Seagen Seen as Unlikely by Earnings Release

Admin16 July 2022

Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized ahead of the pharmaceutical giant’s earnings later this month, though the talks remain on track,...

Business

WSJ News Exclusive | Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More

Admin7 July 2022

Merck MRK -0.20% & Co. is in advanced talks to acquire Seagen Inc. SGEN 2.27% and is aiming to agree on a purchase of the cancer biotech in the next...

Business

Merck Covid-19 Pill Prescribed Frequently in Some Countries Despite Low Efficacy

Admin3 July 2022

Doctors in some countries are frequently prescribing a Covid-19 antiviral from Merck & Co., as safety concerns about a more effective pill from Pfizer Inc. mixing with other medications take...

Business

WSJ News Exclusive | Merck Explores Purchase of Biotech Seagen

Admin18 June 2022

Merck MRK -0.32% & Co. is eyeing a purchase of biotech Seagen Inc., SGEN 12.72% according to people familiar with the matter, a move that would beef up the pharmaceutical...

Business

Pfizer Sales Soar on Covid-19 Vaccine Sales

Admin3 May 2022

Pfizer Inc. PFE 2.22% expects demand for its Covid-19 antiviral drug to increase as governments return to replenish their supplies and seek to thwart surges as the pandemic virus continues...

Business

Pfizer’s Covid-19 Pill Failed Study Testing Its Preventive Use

Admin30 April 2022

The Covid-19 pill from Pfizer Inc. failed to prevent symptomatic infections in adults who had been exposed to the pandemic virus, a late-stage study found. Pfizer said Friday that the...

Business

Katie Haun’s Crypto Venture Capital Funds Break Records

Admin24 March 2022

A new pair of venture-capital funds raised by the Silicon Valley investor Katie Haun has broken records, underscoring the interest in crypto-related startups in a nascent sector known as Web3...